Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

VIRVIR
Showing 8 of 26 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in VIR BIOTECHNOLOGY INC

CITADEL ADVISORS LLC holds 991,337 shares of VIR (VIR BIOTECHNOLOGY INC), worth $10.1M as of 2026-Q2. The position was decreased (-52.8% shares). VIR represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$10.1M

Current Shares

991,337

Total Value Change

+$8.1M

Total Shares Change

+722,365

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
991,337
-52.8%
$10.1M0.0%$10.19
0
2026-Q1
Increased
2.1M
+328.9%
$18.8M0.0%$8.91
46
2025-Q4
Decreased
489,226
-38.8%
$3M0.0%$5.84
0
2025-Q3
Decreased
799,034
-76.9%
$4.6M0.0%$5.63
0
2025-Q2
Increased
3.5M
+114.3%
$17.5M0.0%$5.17
46
2025-Q1
Increased
1.6M
+496.2%
$10.5M0.0%$6.70
45
2024-Q4
Increased
271,264
+0.8%
$2M0.0%$7.33
26
2024-Q3
Decreased
268,972
-64.1%
$2M0.0%$7.53
0

Other major holders of VIR: SB INVESTMENT ADVISERS (UK) LTD

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used